Dr Ojala's (Cutter) memo of a meeting on non-specific (surrogate) testing stated: "The approval of our heat-treat submission, in conjunction with core-screened plasma could present us with a potent marketing advantage. We made no mention of our plans to the others." Read more about Dr Ojala's (Cutter) memo of a meeting on non-specific (surrogate) testing stated: "The approval of our heat-treat submission, in conjunction with core-screened plasma could present us with a potent marketing advantage. We made no mention of our plans to the others."
Dr Ojala's (Cutter) memo of a meeting on non-specific (surrogate) testing concluded: "In summary, the conclusion of this meeting was that the time had come for Hepatitis core anti-body testing for plasma. Implementation will probably be achieved during 1984 for the industry." Read more about Dr Ojala's (Cutter) memo of a meeting on non-specific (surrogate) testing concluded: "In summary, the conclusion of this meeting was that the time had come for Hepatitis core anti-body testing for plasma. Implementation will probably be achieved during 1984 for the industry."
Strategy caucuses of the plasma collection and manufacturing interests in advance of their meeting regulators, the CDC and others were to become a common occurrence. Read more about Strategy caucuses of the plasma collection and manufacturing interests in advance of their meeting regulators, the CDC and others were to become a common occurrence.
The New England Journal of Medicine published an article by Durack titled "Opportunistic infections and Kaposi's sarcoma in homosexual men". Read more about The New England Journal of Medicine published an article by Durack titled "Opportunistic infections and Kaposi's sarcoma in homosexual men".
The New England Journal of Medicine published an article by Masur et al titled "An outbreak of community-acquired pneumocystis carinii pneumonia". Read more about The New England Journal of Medicine published an article by Masur et al titled "An outbreak of community-acquired pneumocystis carinii pneumonia".
"The New England Journal of Medicine", published an article by Gottlieb et al titled "Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men". Read more about "The New England Journal of Medicine", published an article by Gottlieb et al titled "Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men".
The evidence is that after February 1983 any remaining stocks of factor concentrates that had been prepared by Cutter using prison plasma were used for research and development purposes only. Read more about The evidence is that after February 1983 any remaining stocks of factor concentrates that had been prepared by Cutter using prison plasma were used for research and development purposes only.
William Srigley of Cutter Pharmaceutical gave evidence that he was aware before July 1982 that a homosexual donor who was hepatitis positive risked transmitting AIDS. Read more about William Srigley of Cutter Pharmaceutical gave evidence that he was aware before July 1982 that a homosexual donor who was hepatitis positive risked transmitting AIDS.
Cutter confirmed that all plasma was being collected from FDA licensed and inspected centres. Read more about Cutter confirmed that all plasma was being collected from FDA licensed and inspected centres.
Patient information leaflets became a legal requirement in the UK for all medicines. Read more about Patient information leaflets became a legal requirement in the UK for all medicines.